/Investor DB

Majuven

Venture capital

Singapore · Seed–Series B · 4 people tracked

Find your way into Majuven

Sign up to see every warm intro you have to Majuven

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Majuven team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Majuven invests in disruptive and evolving high-tech trends across healthcare, financial services and digital consumerism. It typically backs companies from the Seed stage through Series B, usually once a company has begun executing a clear monetization strategy. The firm emphasizes supporting portfolio companies with regional expansion across Asia, drawing on its founding partners' extensive corporate networks and influential contacts. Beyond capital, Majuven offers deep domain expertise and a track record of building large businesses, advising entrepreneurs on strategy, operations, marketing, deal making and capital raising.

Source: firm website, verified Oct 25, 2026.

Stage
Seed–Series B
HQ
Singapore, SG
Instruments
Equity
Founded
2012
Tracked investments
2

Team · 4 people

from the firm's website & public directories
Lim Ho Kee· Founding & Managing Partner

A veteran banker with extensive corporate experience, including a 15-year career at UBS AG Switzerland where he rose to CEO and Chairman of UBS East Asia and became the first non-Swiss member of the Enlarged Group Executive Board. He has also held directorships at SingTel, Keppel Tatlee Bank, K1 Ventures, and Singapore Post, with earlier roles at Overseas Union Bank, the Monetary Authority of Singapore, and JP Morgan.

Low Teck Seng· Founding Partner

A distinguished academic and research leader who served as CEO of Singapore's National Research Foundation and previously as Managing Director of A*STAR. A tenured NTU professor and former Dean of Engineering at NUS, he was the founding Principal of Republic Polytechnic and recipient of Singapore's National Science and Technology Medal and the Public Administration Medal (Gold).

Lu Yoh Chie· Founding Partner

Founder and former Chairman and CEO of Biosensors International Group, with more than 30 years of experience in the medical industry. He previously built Asia-based operations for Gould Inc.'s Medical Division, led a management buyout that became the Nasdaq-listed Spectramed, and founded several medical companies now under Biosensors.

Ho Kee Lim· Managing Partner

What they invest in

from 1 of 2 portfolio companies

Healthtech ×1

HQs:United States×1

Investments · 2 tracked

founders shown can be your intro path

By year:2025 · 12017 · 12 dated

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Trendlines GroupM17

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Frequently asked questions

What stage does Majuven invest at?
Majuven invests at the Seed, Series A, Series B stages.
What sectors does Majuven focus on?
Majuven focuses on Biotech, Consumer, Digital Health, Energy, Enterprise Software, Fintech, Healthtech, Media & Entertainment, Medical Devices, Semiconductors.
Where is Majuven located?
Majuven is headquartered in Singapore, SG.

Images

Majuven photo

Similar investors

Featured in lists